|Project Title||Non-Melanoma Skin Cancer following Hydrochlorothiazide Use: A Propensity Score Matched Analysis|
Tuesday, June 11, 2019
This analysis investigates the risk of non-melanoma skin cancer for patients treated with hydrochlorothiazide-containing products compared to non-hydroclorothiazide angiotensin-converting-enzyme inhibitor (ACEI)-containing products, including captopril, enalapril maleate, and lisinopril monotherapies and combination therapies in the Sentinel Distributed Database.
The analytic package associated with this analysis can be found externally in Sentinel's Git Repository located here. The Git Repository serves as Sentinel's version control tracking system for analytic packages and technical documentation.
non-melanoma skin cancer
|Population / Cohort||
January 1, 2000 - February 1, 2019
Sentinel Distributed Database (SDD)
- Vaccines, Blood & Biologics
- Devices and Radiologic Health